Press Releases
December 22, 2022
MediPharm Labs Corp. to Acquire VIVO Cannabis Inc.
Two global leaders in the medical wellness cannabis industry expected to combine complementary strengths of diversified revenue in multiple markets and channels to create a pro-forma Combined Company with over $50M in annualized revenue, based on Q3 2022.(1)(2)(3)(4) Pro-forma Combined Company is expected to have positive EBITDA(5) synergies of between $7M to $9M on an […]
Read MoreNovember 14, 2022
VIVO Cannabis Announces Third Quarter 2022 Results
Net revenue for Q3 2022 was $6.2 million, a 19% increase from prior quarter International sales reach $2.5 million Beacon Medical continues to be the leading medical cannabis flower brand in Australia The Company entered into a third supplement to the indenture for its debentures to extend their maturity to 2024 Subsequent to the quarter-end, […]
Read MoreOctober 3, 2022
VIVO Cannabis Announces Third Supplemental Debenture Indenture
Toronto, Ontario–(Newsfile Corp. – October 3, 2022) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“) is pleased to announce that, further to the Company’s news release of September 19, 2022, the Company has entered into a third supplemental debenture indenture dated September 29, 2022 (the “Supplemental Indenture“) with TSX Trust Company […]
Read MoreSeptember 19, 2022
VIVO Cannabis Announces Agreement to Amend Outstanding Debentures
Toronto, Ontario–(Newsfile Corp. – September 19, 2022) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“) has entered into an agreement dated September 15, 2022 with the majority beneficial owner of its outstanding unsecured convertible debentures dated February 28, 2018 in the aggregate principal amount of $5,546,808 (collectively, the “Debentures“) to amend […]
Read MoreAugust 15, 2022
VIVO Cannabis Announces Second Quarter 2022 Results
Net revenue for Q2 2022 was $5.2 million Company announced that Canna Farms received a Research Licence from Health Canada in June, 2022 Canadian Launch of Fireside™ Pink Kush and Girl Scout Cookies Full-Spectrum 510 Vapes Australian sales delayed due to new regulatory requirements Company announces cost savings workforce reductions focused on its Hope, BC […]
Read MoreJuly 22, 2022
VIVO Cannabis Announces Canna Farms Granted Research Licence by Health Canada
Toronto, Ontario–(Newsfile Corp. – July 22, 2022) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO“ or the “Company“), a leading provider of medical cannabis products and patient services, and holder of licences under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited (“Canna Farms”), ABcann Medicinals Inc., today announced that Canna Farms has […]
Read MoreJuly 1, 2022
VIVO Cannabis Announces Results of 2022 AGM and Election of New Directors
Toronto, Ontario–(Newsfile Corp. – July 2, 2022) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services, is pleased to announce the results of its annual general and special meeting of shareholders held today (the "Meeting"). As announced this morning, at the Meeting, shareholders […]
Read MoreJune 3, 2022
VIVO Cannabis Announces Publication of Medical Cannabis Clinical Research Study in Psychiatric Research: Anxiety & Depression Outcomes in Medical Cannabis Patients
Toronto, Ontario–(Newsfile Corp. – June 3, 2022) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO“ or the “Company“), a leading provider of medical cannabis products and patient services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited (“Canna Farms”), ABcann Medicinals Inc., today announced results from its first […]
Read MoreMay 16, 2022
VIVO Cannabis Announces First Quarter 2022 Results
Net revenue for Q1 2022 was $6.9 million VIVO continues to pursue its international expansion strategy which now represents >50% of cannabis revenue Canadian Launch of Canna Farms Single-strain Oils, Infused Pre-rolls, Top Cola Signature Series and Fireside CBD Canna Bliss 510 Vape Cartridge and 10 pack CBD Chocolates Harvest Medicine study on medical cannabis […]
Read MoreMarch 31, 2022
VIVO Cannabis Announces Fourth Quarter 2021 Results
Net revenue for Q4 2021 was $6.9 million; Net revenue for 2021 was $25 million. In February 2021, closed a $7.2 million equity raise to help fund VIVO’s growth In July 2021, the Company elected a new Board of Directors, announced the appointment of Ray Laflamme as CEO and Chairman of the Board and later […]
Read More
